KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Euronext Milan - NL0000009538 - Common Stock - Currency: EUR
Taking everything into account, 1PHIA scores 3 out of 10 in our fundamental rating. 1PHIA was compared to 59 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of 1PHIA have multiple concerns. 1PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1PHIA was profitable.
In the past year 1PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1PHIA reported negative net income in multiple years.
Of the past 5 years 1PHIA 4 years had a positive operating cash flow.
1.2 Ratios
1PHIA has a Return On Assets of -2.42%. This is in the lower half of the industry: 1PHIA underperforms 61.02% of its industry peers.
1PHIA has a Return On Equity of -5.85%. This is in the lower half of the industry: 1PHIA underperforms 61.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1PHIA's Operating Margin has declined in the last couple of years.
The Gross Margin of 1PHIA (43.13%) is worse than 71.19% of its industry peers.
In the last couple of years the Gross Margin of 1PHIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for 1PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
1PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1PHIA has been reduced compared to 1 year ago.
The number of shares outstanding for 1PHIA has been increased compared to 5 years ago.
1PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.53, we must say that 1PHIA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.53, 1PHIA is doing worse than 61.02% of the companies in the same industry.
The Debt to FCF ratio of 1PHIA is 8.68, which is on the high side as it means it would take 1PHIA, 8.68 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1PHIA (8.68) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.59 indicates that 1PHIA is somewhat dependend on debt financing.
1PHIA's Debt to Equity ratio of 0.59 is on the low side compared to the rest of the industry. 1PHIA is outperformed by 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.53 |
ROIC/WACCN/A
WACC6.28%
2.3 Liquidity
1PHIA has a Current Ratio of 1.23. This is a normal value and indicates that 1PHIA is financially healthy and should not expect problems in meeting its short term obligations.
1PHIA has a Current ratio of 1.23. This is in the lower half of the industry: 1PHIA underperforms 69.49% of its industry peers.
1PHIA has a Quick Ratio of 1.23. This is a bad value and indicates that 1PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
1PHIA has a worse Quick ratio (0.84) than 64.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.45% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
1PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
1PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
3.2 Future
The Earnings Per Share is expected to grow by 12.99% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.55% on average over the next years.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.18 indicates a correct valuation of 1PHIA.
Based on the Price/Earnings ratio, 1PHIA is valued cheaply inside the industry as 91.53% of the companies are valued more expensively.
1PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.32.
The Price/Forward Earnings ratio is 11.36, which indicates a very decent valuation of 1PHIA.
Based on the Price/Forward Earnings ratio, 1PHIA is valued cheaper than 86.44% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, 1PHIA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.18 | ||
| Fwd PE | 11.36 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1PHIA is valued a bit cheaper than the industry average as 66.10% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, 1PHIA is valued cheaper than 84.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.9 | ||
| EV/EBITDA | 17.11 |
4.3 Compensation for Growth
1PHIA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1PHIA's earnings are expected to grow with 12.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.43
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
No dividends for 1PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1PHIA (6/17/2025, 7:00:00 PM)
19.57
-0.92 (-4.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap18.39B
Analysts73.08
Price Target28.59 (46.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.27%
Min EPS beat(2)-16.56%
Max EPS beat(2)-11.97%
EPS beat(4)0
Avg EPS beat(4)-12.16%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.79%
EPS beat(12)3
Avg EPS beat(12)3.3%
EPS beat(16)5
Avg EPS beat(16)1.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.04%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-2.46%
Revenue beat(8)1
Avg Revenue beat(8)-2.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-2.44%
PT rev (1m)-1.3%
PT rev (3m)-1.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.78%
Revenue NY rev (1m)-2.65%
Revenue NY rev (3m)-3.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.18 | ||
| Fwd PE | 11.36 | ||
| P/S | 1.02 | ||
| P/FCF | 20.9 | ||
| P/OCF | 11.82 | ||
| P/B | 1.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.11 |
EPS(TTM)1.38
EY7.05%
EPS(NY)1.72
Fwd EY8.81%
FCF(TTM)0.94
FCFY4.78%
OCF(TTM)1.66
OCFY8.46%
SpS19.17
BVpS12.77
TBVpS-1.45
PEG (NY)1.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.53 |
F-Score6
WACC6.28%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.55%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%